logo-loader

Kalytera Therapeutics Inc

Receive alerts
Market:
OTCMKTS
Market Cap:
$9.79 m
Price
0.02 USD
Change
5.56%
52 weeks high
0.09
52 weeks low
0.02

In brief

Kalytera Therapeutics Inc (TSX-V: KALY, OTCQB: KALTF) is a clinical-stage specialty pharmaceutical company, develops cannabinoid medicines for a range of unmet medical needs. It is developing cannabidiol formulations to prevent and treat acute graft versus host diseases.